5.B - top down and bottom up strategies Flashcards
key idea
- whether its better/easier/more effective to use top down or bottom up strategies for disease eradication
what are top down strategies?
- government led campaigns to eradicate diseases using a combination of direct/indirect strategies often with people being told what to do
what are bottom up strategies?
- where communities make their own strategies and they are consulted
- often this is with NGOs and relies more on indirect strategies such as sdeducation to tackle disease
what role do TNCs play in disease eradication?
- e.g. GlaxoSmithKlein
- for diseases to be eradicated on whatever scale, you need a TNC with the wealth, expertise and resources to generate the drugs, the technology to administer the drugs and the ability to modify these if/when the disease mutates
- political will is also needed, as is money to pay. often comes from national govts/international agencies eg. WHO or large aid investors e.g. Bill and Melinda Gates
why are top down sometimes unsuccessful?
- social/cultural reasons
- e.g. difficult to eradicate Polio in Pakistan as the Taliban, who control large areas of Pakistan, have not allowed the vaccines to be administered
- there have been enormous movements of people which have meant that it has been hard to keep track of who has/has not been vaccinated
- there was a distinct mistrust of the ‘outsiders’ coming in to vaccinate children
where do bottom up strategies come into play?
- it is essential that the country/people in the country ‘buy in’ to the eradication strategy and this is where the conceptual approach of bottom up strategies come into play
- where local people and communities are trained/educated and then worked with collaboratively to tackle a disease
- often working with women in these communities is most important as in LIDCs women will do most of the household chores/raise the children.
who are GSK
- GlaxoSmithKline
- Market capitalisation of £81 billion
- drugs and vaccines earned £21.3 billion in 2013
why do GSK have a bad reputation in Africa?
- bad reputation in Africa for high cost of HIV drugs in the past
- they sold their drug 5000x more expensive than it is. reinvented an existing drug for a limited market.
- to reform, they have controversially partnered with Save the Children, aiming not to generate profit or loss by donating £15 bill in 2013
what do GSK want?
- to tackle the root cause of disease
- help transform millions of lives
- working to get new treatments to everyone who needs it
- price their products at levels each country is able to pay
- they’ve reached 300,000 patients, 64 countries and 300 clinical trials so far
GSK criminal trial
- pleased guilty to the promotion of drugs for unapproved uses and failure to report safety data
- “Advair” = asthma drug sold for uses that weren’t approved by FDA
- paid £1.9bn settlement
- largest healthcare fraud to date
when have GSK faced criticism?
- in 2009 they said they would cut drug prices by 25% for 50 poorest nations
- criticised for not helping NEEs and excluding HIV from this
how many countries do GSK work in?
operations are global with 84 manufacturing sites in 36 different countries
what is their main turnover?
2/3 of their turnover is from pharmaceuticals, including medicines for a range of acute and chronic diseases
how may vaccines where distributed in 2014 and where did most go?
- over 800 million doses of vaccines
- of which 80% went to countries in the developing world
give 3 well known drugs that it distributes
- Amoxicillin to fight bacterial infections
- Zidovudine for HIV infection
- bendazole to combat parasitic infections
- the drugs are on WHO’s list of essential medicines
outline GSK’s investment in research and development
- employs 13,000 people in R&D and spends more than £3 billion researching new medecines
- usually taken in partnership w/ other companies, unis and research charities